KMT2A and acute myeloid leukemia: Latent AML with a short life span, extensive extramedullary involvement and increased aggressivenessNormal chromosomal structuresReduced MLL-WT expressionLoss of FLT3-WT and increased total FLT3 expressionIncreased HOXA9 transcript levels